More than 60% of health care professionals report having trust and organizational support for using AI in their practices, ...

We spoke with a nurse expert on artificial intelligence who advises hospitals and health systems about potential hazards when ...

The company expects to share safety and efficacy results from the RAMP-205 expansion cohort in first-line advanced pancreatic cancer and initial results from the Phase I/IIa trial evaluating VS-7375 ...

Aurinia's Q3 2025 saw 27% LUPKYNIS sales growth and raised 2025 guidance. Discover key earnings insights, clinical updates, and pipeline progress.

New clinician-guided program blends medical science, microdosing, and 24/7 support to make advanced weight loss and wellness ...

While accuracy on menopause and other medical topics may improve with time, patients and clinicians should always confirm answers with reliable sources.

Pfizer has axed 11 programs, including two pipeline assets from its $43 billion Seagen acquisition, work on a ...

At-home gut microbiome tests are trending, selling insights to the curious, empowerment to the chronically ill and a claimed ...

The market for digital EAPs is maturing. Hype is giving way to evidence, and leaders who keep asking hard questions can ...

Deciding what to eat, where to get it, and how those choices align with health goals or cultural habits are ordinary parts of ...

The FDA-approved drug Pluvicto offers hope for advanced prostate cancer patients, but access barriers remain despite proven ...

Learn how AI therapy and chatbots work, what they can’t replace, and why human connection still matters in mental health care ...